Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
$43.12
$45.05
$33.20
$46.95
$11.53B1.06373 shs15 shs
Barratt Developments plc stock logo
BTDPY
Barratt Developments
$11.22
-2.3%
$11.86
$9.45
$14.55
$5.47B1.6811,905 shs2,404 shs
CapitaLand Limited stock logo
CLLDY
CapitaLand
$6.21
+3.4%
$6.21
$3.65
$6.31
$16.16B1.0710,943 shs3,800 shs
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
$12.32
+1.3%
$11.03
$7.67
$15.48
$6.18B0.7276,965 shs50,810 shs
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$51.60
$51.60
$51.60
$51.98
N/A0.32N/AN/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
0.00%-4.18%-5.65%+6.97%+4.79%
Barratt Developments plc stock logo
BTDPY
Barratt Developments
+3.70%+4.17%-4.33%-15.67%-4.57%
CapitaLand Limited stock logo
CLLDY
CapitaLand
0.00%0.00%0.00%0.00%0.00%
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
-1.61%-6.17%+3.49%+23.83%-17.05%
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
0.00%0.00%0.00%+12.17%+26.07%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
N/AN/AN/AN/AN/AN/AN/AN/A
Barratt Developments plc stock logo
BTDPY
Barratt Developments
1.8434 of 5 stars
0.03.01.70.02.50.02.5
CapitaLand Limited stock logo
CLLDY
CapitaLand
N/AN/AN/AN/AN/AN/AN/AN/A
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
2.3718 of 5 stars
0.04.01.70.02.60.02.5
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
N/AN/AN/AN/A
Barratt Developments plc stock logo
BTDPY
Barratt Developments
2.00
HoldN/AN/A
CapitaLand Limited stock logo
CLLDY
CapitaLand
N/AN/AN/AN/A
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
N/AN/AN/AN/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
2.00
HoldN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
$7.05B1.63$8.12 per share5.31$51.83 per share0.83
Barratt Developments plc stock logo
BTDPY
Barratt Developments
$6.66B0.82$1.78 per share6.29$13.83 per share0.81
CapitaLand Limited stock logo
CLLDY
CapitaLand
$4.74B3.41N/AN/A$13.31 per share0.47
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
$1.81B3.41$0.39 per share31.67$1.23 per share10.02
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$1.95BN/A$3.06 per share16.86$7.90 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
$1.92B$7.645.647.83N/A20.27%15.01%1.09%N/A
Barratt Developments plc stock logo
BTDPY
Barratt Developments
$638.80MN/A0.0013.20N/AN/AN/AN/AN/A
CapitaLand Limited stock logo
CLLDY
CapitaLand
-$1.14BN/A0.00N/AN/AN/AN/AN/A
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
$154.87M$0.3238.5032.42N/A8.59%27.56%18.55%N/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$329.08M$1.9326.7418.36N/A18.51%31.80%12.83%N/A

Latest CLLDY, MONOY, BTDPY, BKHYY, and RCDTF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/2/2024Q4 2023
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
N/A$0.09+$0.09$0.10N/A$454.15 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
$0.992.30%N/A12.96%N/A
Barratt Developments plc stock logo
BTDPY
Barratt Developments
$0.201.78%N/AN/AN/A
CapitaLand Limited stock logo
CLLDY
CapitaLand
$0.121.93%N/AN/AN/A
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
$0.060.49%N/A18.75%N/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
N/AN/AN/AN/AN/A

Latest CLLDY, MONOY, BTDPY, BKHYY, and RCDTF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/15/2024
Barratt Developments plc stock logo
BTDPY
Barratt Developments
$0.09924/11/20244/12/20246/3/2024
3/12/2024
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
$0.25213/20/20243/21/20244/18/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
0.47
0.89
0.89
Barratt Developments plc stock logo
BTDPY
Barratt Developments
N/AN/AN/A
CapitaLand Limited stock logo
CLLDY
CapitaLand
0.79
0.95
0.95
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
0.01
2.04
1.53
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
0.80
1.28
0.86

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bank Hapoalim B.M. stock logo
BKHYY
Bank Hapoalim B.M.
8,383267.46 millionN/ANot Optionable
Barratt Developments plc stock logo
BTDPY
Barratt Developments
6,728487.30 millionN/ANot Optionable
CapitaLand Limited stock logo
CLLDY
CapitaLand
10,4732.60 billionN/ANot Optionable
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
1,375501.35 millionN/ANot Optionable
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
4,369N/AN/ANot Optionable

CLLDY, MONOY, BTDPY, BKHYY, and RCDTF Headlines

SourceHeadline
Borsa: Milano fiacca con Recordati e Saipem, vola StmBorsa: Milano fiacca con Recordati e Saipem, vola Stm
msn.com - April 24 at 2:06 PM
Cvc Capital Partners al lavoro sul ‘dossier’ RecordatiCvc Capital Partners al lavoro sul ‘dossier’ Recordati
businesspeople.it - April 24 at 9:06 AM
Recordati scende in Borsa, spunti da analisti e mosse CVCRecordati scende in Borsa, spunti da analisti e mosse CVC
teleborsa.it - April 24 at 9:06 AM
CVC explores options for Italys Recordati, Bloomberg News reportsCVC explores options for Italy's Recordati, Bloomberg News reports
msn.com - April 23 at 6:03 PM
CVC Explores Options for €11 Billion Drugmaker RecordatiCVC Explores Options for €11 Billion Drugmaker Recordati
finance.yahoo.com - April 23 at 6:03 PM
UPDATE 1-CVC explores options for Italys Recordati, Bloomberg News reportsUPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports
finance.yahoo.com - April 23 at 6:03 PM
Recordati, ricavi in aumento del 10,2% nel primo trimestreRecordati, ricavi in aumento del 10,2% nel primo trimestre
teleborsa.it - April 22 at 2:59 PM
Recordati: +10% ricavi I trim. a 607 mln, "forte inizio danno"Recordati: +10% ricavi I trim. a 607 mln, "forte inizio d'anno"
borsaitaliana.it - April 22 at 8:29 AM
Recordati, ok dei soci al bilancio e al dividendo. Landamento dei ricavi nel 1Q2024Recordati, ok dei soci al bilancio e al dividendo. L'andamento dei ricavi nel 1Q2024
soldionline.it - April 22 at 8:29 AM
Recordati, concluso il programma di buybackRecordati, concluso il programma di buyback
finanza.repubblica.it - April 11 at 6:02 PM
Recordati, azioni proprie all1,33% del capitale socialeRecordati, azioni proprie all'1,33% del capitale sociale
teleborsa.it - April 10 at 3:16 PM
Recordati in positivo dopo l’intervista al CEORecordati in positivo dopo l’intervista al CEO
trend-online.com - April 8 at 12:43 PM
Recordati, Investco detiene il 3,014%Recordati, Investco detiene il 3,014%
soldionline.it - March 22 at 6:51 AM
Azionario Italia: Recordati Dopo il Massimo Annuale Scende. OVS Resistenza a 3,25€Azionario Italia: Recordati Dopo il Massimo Annuale Scende. OVS Resistenza a 3,25€
fxempire.it - March 20 at 7:35 PM
Recordati, CdA approva bilancio 2023. Dividendo totale di 1,20 euroRecordati, CdA approva bilancio 2023. Dividendo totale di 1,20 euro
teleborsa.it - March 19 at 1:05 PM
Farmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunitàFarmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunità
msn.com - March 19 at 1:05 PM
Recordati: cda propone dividendo 1,20 per azione, di cui 0,57 gia pagati (RCO)Recordati: cda propone dividendo 1,20 per azione, di cui 0,57 gia' pagati (RCO)
borsa.corriere.it - March 19 at 8:05 AM
Recordati: positivo il superamento dei 53 euroRecordati: positivo il superamento dei 53 euro
milanofinanza.it - February 26 at 8:11 AM
Recordati ben intonato dopo i numeri 2023. Come è andata?Recordati ben intonato dopo i numeri 2023. Come è andata?
trend-online.com - February 25 at 10:26 AM
Le azioni Recordati non brillano dopo i conti, ma il futuro resta molto interessanteLe azioni Recordati non brillano dopo i conti, ma il futuro resta molto interessante
proiezionidiborsa.it - February 23 at 3:53 PM
Analisi Azionaria: STMicroelectronics Sotto Pressione, Recordati Verso nuovi MassimiAnalisi Azionaria: STMicroelectronics Sotto Pressione, Recordati Verso nuovi Massimi
fxempire.it - February 2 at 8:36 AM
Recordati, informativa sul buybackRecordati, informativa sul buyback
teleborsa.it - January 31 at 8:34 PM
Recordati: resistenza grafica a quota 51 euroRecordati: resistenza grafica a quota 51 euro
milanofinanza.it - January 30 at 8:47 AM
Recordati: il titolo allunga al rialzoRecordati: il titolo allunga al rialzo
milanofinanza.it - January 15 at 8:59 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bank Hapoalim B.M. logo

Bank Hapoalim B.M.

OTCMKTS:BKHYY
Bank Hapoalim B.M., together with its subsidiaries, provides various banking and financial products and services in Israel and internationally. It operates through Household, Private Banking, Small businesses and micro businesses, Mid-sized businesses, Large businesses, Institutional entities, and Financial management segments. The company offers account-management services, lending for various purposes, deposits, and savings plans, and capital-market service; housing loans; research and advisory services; and pension advisory and retirement planning services. It also provides products and services for the expansion of a business, advanced digital services, and a service center specializing in businesses; credit for routine operations and investment financing, guarantees, letters of credit, foreign trade, and transactions in financial and derivative instruments, as well as investment services in various channels, such as foreign currency, shekels, and securities. In addition, the company offers financial services, including foreign-trade financing, financing of working capital, financing of assets overseas, complex financing transactions, syndication, and credit-risk transfers; and financing of construction projects, granting credit to customers, and issuing guarantees to buyers of homes. Further, it provides managers of mutual funds, managers of investment portfolios, and managers of provident funds, study funds, and pension funds; trading activities; underwriting services; and brokerage and custody services. The company serves households, private-banking customers, foreign residents, small businesses, financial-asset managers, middle-market business clients, and large corporations. Bank Hapoalim B.M. was founded in 1921 and is based in Tel Aviv, Israel.
Barratt Developments logo

Barratt Developments

OTCMKTS:BTDPY
Barratt Developments plc engages in the housebuilding business in the United Kingdom. The company acquires and develops land; plans, designs, and constructs homes, apartments, penthouses, and communities, as well as undertakes mixed-use regeneration schemes; and develops retail, leisure, office, industrial, and mixed-use properties. It is also involved in the commercial development business under the Wilson Bowden Developments brand name. The company offers its homes under the Barratt Homes, David Wilson Homes, and Barratt London brands. The company was incorporated in 1958 and is headquartered in Coalville, the United Kingdom.
CapitaLand logo

CapitaLand

OTCMKTS:CLLDY
CapitaLand is one of Asia's largest real estate companies headquartered and listed in Singapore. The company leverages its significant asset base, design and development capabilities, active capital management strategies, and extensive market network and operational capabilities to develop high-quality real estate products and services. Its diversified global real estate portfolio includes integrated developments, shopping malls, serviced residences, offices and homes. The Group focuses on Singapore and China as our core markets, while it continues to expand in markets such as Vietnam and Indonesia. The company also has one of the largest real estate fund management businesses with assets located in Asia.
MonotaRO logo

MonotaRO

OTCMKTS:MONOY
MonotaRO Co., Ltd., together with its subsidiaries, operates an online MRO products store in Japan and internationally. It offers products in various categories, such as safety protection equipment, work clothes, and safety shoes; logistics, storage, and packing supplies; tapes; safety supplies/safety signs; office supplies; office furniture/lighting/cleaning supplies; cutting tools/abrasives; measurement/surveying supplies; work/electric/pneumatic tools; spray/oil/grease/paint/adhesion/repair/welding supplies; and agricultural materials/gardening supplies. The company also provides building hardware products, building materials, and painting interior supplies; air conditioning/electrical equipment materials/electrical materials; piping/water supply/pump/pneumatic/hydraulic equipment/hose products; mechanical parts; control equipment/solder/static electricity countermeasure supplies; screws/bolts/nails/materials; car/truck supplies; motorcycle/bicycle supplies; kitchen equipment/kitchen products/store supplies; scientific research and development/clean room supplies; and medical/long-term care products. It serves factories, construction, automobile maintenance, and other industries. The company was formerly known as Sumisho Grainger Co., Ltd. and changed its name to MonotaRO Co., Ltd. in 2006. MonotaRO Co., Ltd. was founded in 2000 and is headquartered in Amagasaki, Japan. MonotaRO Co., Ltd. operates as a subsidiary of Grainger Global Holdings, Inc.
Recordati Industria Chimica e Farmaceutica logo

Recordati Industria Chimica e Farmaceutica

OTCMKTS:RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.